SLS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sellas Life Sciences Group Inc (SLS).


$73.20M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

SLS Market Cap. (MRY)


SLS Shares Outstanding (MRY)


SLS Assets (MRY)


Total Assets

$19.43M

Total Liabilities

$9.97M

Total Investments

$0

SLS Income (MRY)


Revenue

$0

Net Income

-$30.88M

Operating Expense

$31.51M

SLS Cash Flow (MRY)


CF Operations

-$35.40M

CF Investing

$0

CF Financing

$46.76M

SLS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SLS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$19,432,000 (212.46%)

$6,219,000 (-70.31%)

$20,943,000 (-20.29%)

$26,275,000 (-42.94%)

Assets Current

$16,327,000 (414.72%)

$3,172,000 (-82.14%)

$17,756,000 (-22.95%)

$23,044,000 (-37.59%)

Assets Non-Current

$3,105,000 (1.90%)

$3,047,000 (-4.39%)

$3,187,000 (-1.36%)

$3,231,000 (-64.59%)

Goodwill & Intangible Assets

$1,914,000 (0.00%)

$1,914,000 (0.00%)

$1,914,000 (0.00%)

$1,914,000 (0.00%)

Shareholders Equity

$9,465,000 (218.67%)

-$7,976,000 (-264.42%)

$4,851,000 (-76.16%)

$20,347,000 (-27.23%)

Property Plant & Equipment Net

$925,000 (7.81%)

$858,000 (-1.83%)

$874,000 (20.89%)

$723,000 (-19.31%)

Cash & Equivalents

$13,986,000 (431.79%)

$2,630,000 (-84.73%)

$17,225,000 (-19.72%)

$21,455,000 (-39.40%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,500,000 (-37.93%)

$5,639,000 (67.98%)

$3,357,000 (56.58%)

$2,144,000 (-53.96%)

Accumulated Retained Earnings (Deficit)

-$248,125,000 (-14.21%)

-$217,244,000 (-20.76%)

-$179,904,000 (-29.80%)

-$138,603,000 (-17.56%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,001,000 (10.49%)

$906,000 (-4.13%)

$945,000 (16.96%)

$808,000 (-18.47%)

Debt Current

$544,000 (21.97%)

$446,000 (19.89%)

$372,000 (87.88%)

$198,000 (19.28%)

Debt Non-Current

$457,000 (-0.65%)

$460,000 (-19.72%)

$573,000 (-6.07%)

$610,000 (-26.06%)

Total Liabilities

$9,967,000 (-29.79%)

$14,195,000 (-11.79%)

$16,092,000 (171.46%)

$5,928,000 (-67.23%)

Liabilities Current

$9,510,000 (-30.76%)

$13,735,000 (-11.47%)

$15,515,000 (211.42%)

$4,982,000 (-59.61%)

Liabilities Non-Current

$457,000 (-0.65%)

$460,000 (-20.28%)

$577,000 (-39.01%)

$946,000 (-83.55%)

SLS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$1,000,000 (-86.84%)

$7,600,000 (300.00%)

Cost of Revenue

$0 (0%)

$0 (0%)

$100,000 (-50.00%)

$200,000 (0%)

Selling General & Administrative Expense

$12,417,000 (-10.42%)

$13,862,000 (10.17%)

$12,582,000 (11.15%)

$11,320,000 (17.92%)

Research & Development Expense

$19,096,000 (-20.46%)

$24,007,000 (18.45%)

$20,268,000 (29.31%)

$15,674,000 (68.86%)

Operating Expenses

$31,513,000 (-16.78%)

$37,869,000 (-11.62%)

$42,850,000 (31.06%)

$32,694,000 (73.15%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

-$237,000 (-1294.12%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$30,881,000 (17.30%)

-$37,340,000 (9.59%)

-$41,301,000 (-99.53%)

-$20,699,000 (-23.52%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$30,881,000 (17.30%)

-$37,340,000 (9.59%)

-$41,301,000 (-99.53%)

-$20,699,000 (-23.52%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$30,881,000 (17.30%)

-$37,340,000 (9.59%)

-$41,301,000 (-99.53%)

-$20,699,000 (-22.95%)

Weighted Average Shares

$61,202,412 (120.33%)

$27,777,111 (43.21%)

$19,395,709 (25.29%)

$15,481,113 (94.07%)

Weighted Average Shares Diluted

$61,202,412 (120.33%)

$27,777,111 (43.21%)

$19,395,709 (25.29%)

$15,481,113 (94.07%)

Earning Before Interest & Taxes (EBIT)

-$30,881,000 (17.30%)

-$37,340,000 (9.59%)

-$41,301,000 (-97.27%)

-$20,936,000 (-24.81%)

Gross Profit

$0 (0%)

$0 (0%)

$900,000 (-87.84%)

$7,400,000 (289.47%)

Operating Income

-$31,513,000 (16.78%)

-$37,869,000 (9.73%)

-$41,950,000 (-65.85%)

-$25,294,000 (-48.95%)

SLS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

-$5,500,000 (-22.22%)

-$4,500,000 (0%)

$0 (0%)

Net Cash Flow from Financing

$46,758,000 (109.54%)

$22,315,000 (-7.33%)

$24,079,000 (99.43%)

$12,074,000 (-68.59%)

Net Cash Flow from Operations

-$35,402,000 (-12.71%)

-$31,410,000 (-31.92%)

-$23,809,000 (8.50%)

-$26,021,000 (-149.79%)

Net Cash Flow / Change in Cash & Cash Equivalents

$11,356,000 (177.81%)

-$14,595,000 (-245.04%)

-$4,230,000 (69.67%)

-$13,947,000 (-149.77%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$5,500,000 (-22.22%)

-$4,500,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$46,822,000 (109.53%)

$22,346,000 (-7.20%)

$24,079,000 (99.43%)

$12,074,000 (-68.59%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,564,000 (-25.31%)

$2,094,000 (21.32%)

$1,726,000 (70.72%)

$1,011,000 (74.91%)

Depreciation Amortization & Accretion

$561,000 (13.33%)

$495,000 (8.32%)

$457,000 (164.16%)

$173,000 (82.11%)

SLS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

90.00% (-7.60%)

97.40% (-2.60%)

Profit Margin

-

-

-4130.10% (-1416.19%)

-272.40% (69.26%)

EBITDA Margin

-

-

-4084.40% (-1395.02%)

-273.20% (68.88%)

Return on Average Equity (ROAE)

-325.50% (86.47%)

-2405.50% (-490.16%)

-407.60% (-437.02%)

-75.90% (46.17%)

Return on Average Assets (ROAA)

-144.50% (40.04%)

-241.00% (-46.77%)

-164.20% (-194.27%)

-55.80% (20.40%)

Return on Sales (ROS)

-

-

-4130.10% (-1399.13%)

-275.50% (68.79%)

Return on Invested Capital (ROIC)

432.20% (20.22%)

359.50% (-26.45%)

488.80% (203.85%)

-470.70% (8.33%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.08 (-162.96%)

-0.79 (28.61%)

-1.11 (73.15%)

-4.13 (-49.85%)

Price to Sales Ratio (P/S)

-

-

45.77 (306.34%)

11.27 (-53.82%)

Price to Book Ratio (P/B)

7.73 (281.48%)

-4.26 (-142.54%)

10.02 (132.01%)

4.32 (119.58%)

Debt to Equity Ratio (D/E)

1.05 (159.16%)

-1.78 (-153.66%)

3.32 (1039.86%)

0.29 (-55.02%)

Earnings Per Share (EPS)

-0.5 (62.69%)

-1.34 (37.09%)

-2.13 (-58.96%)

-1.34 (36.49%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0.05 (-89.41%)

0.49 (106.30%)

Free Cash Flow Per Share (FCFPS)

-0.58 (48.89%)

-1.13 (7.90%)

-1.23 (26.95%)

-1.68 (-28.71%)

Book Value Per Share (BVPS)

0.15 (154.01%)

-0.29 (-214.80%)

0.25 (-80.97%)

1.31 (-62.51%)

Tangible Assets Book Value Per Share (TABVPS)

0.29 (84.52%)

0.15 (-84.20%)

0.98 (-37.67%)

1.57 (-71.55%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (-100.00%)

-1 (0.00%)

-1 (66.67%)

-3 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.74 (-109.41%)

-0.83 (-20.14%)

-0.69 (77.02%)

-3 (-5.00%)

Asset Turnover

0 (0%)

0 (0%)

0.04 (-80.49%)

0.2 (159.49%)

Current Ratio

1.72 (643.29%)

0.23 (-79.81%)

1.14 (-75.26%)

4.63 (54.53%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$35,402,000 (-12.71%)

-$31,410,000 (-31.92%)

-$23,809,000 (8.50%)

-$26,021,000 (-149.79%)

Enterprise Value (EV)

$52,642,258 (72.25%)

$30,560,993 (8.46%)

$28,176,263 (-54.79%)

$62,323,047 (30.71%)

Earnings Before Tax (EBT)

-$30,881,000 (17.30%)

-$37,340,000 (9.59%)

-$41,301,000 (-97.27%)

-$20,936,000 (-24.81%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$30,320,000 (17.71%)

-$36,845,000 (9.79%)

-$40,844,000 (-96.72%)

-$20,763,000 (-24.49%)

Invested Capital

-$4,977,000 (55.38%)

-$11,154,000 (12.63%)

-$12,766,000 (-906.78%)

-$1,268,000 (51.45%)

Working Capital

$6,817,000 (164.54%)

-$10,563,000 (-571.35%)

$2,241,000 (-87.59%)

$18,062,000 (-26.54%)

Tangible Asset Value

$17,518,000 (306.92%)

$4,305,000 (-77.38%)

$19,029,000 (-21.89%)

$24,361,000 (-44.80%)

Market Capitalization

$73,197,258 (115.37%)

$33,985,993 (-30.05%)

$48,588,263 (-44.69%)

$87,847,047 (59.80%)

Average Equity

$9,488,500 (511.27%)

$1,552,250 (-84.68%)

$10,132,500 (-62.85%)

$27,277,750 (128.49%)

Average Assets

$21,372,500 (37.94%)

$15,493,750 (-38.39%)

$25,147,000 (-32.23%)

$37,106,500 (54.45%)

Invested Capital Average

-$7,145,000 (31.20%)

-$10,385,750 (-22.91%)

-$8,450,000 (-289.99%)

$4,447,500 (36.14%)

Shares

70,381,979 (119.52%)

32,062,258 (55.73%)

20,588,247 (29.60%)

15,885,542 (67.89%)